Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Qitai Pharmaceutical is a leading pharmaceutical retail and wholesale enterprise headquartered in Qitaihe, Heilongjiang Province, China. Founded in 2002, the company has grown into one of the largest pharmacy chains in Northeast China, operating hundreds of retail outlets and a comprehensive logistics network. In 2021, the company was acquired by Laobaixing Pharmacy Chain (LBX Pharmacy), a leading national pharmacy group, to bolster its presence in the regional market. Qitai Pharmaceutical specializes in the commercial distribution of pharmaceuticals, medical devices, and health supplements. It does not engage in primary drug discovery or clinical-stage R&D, focusing instead on the healthcare supply chain and retail services. The company is recognized as a key player in the regional healthcare infrastructure, providing essential medical access to millions of residents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Qitai Pharmaceutical.